| MARKET APPLICABILITY
Intralytix
believes that the market for phages is significant and diversified.
In the medical arena, the company plans to package it products for the
following usage:
- As a therapeutic agent
to treat bacterial infections, especially those caused by
multi-drug resistant microorganisms and against which there is no
currently available or effective treatment modality. One such
application would target infection caused by vancomycin-resistant
enterococci (VRE);
- As a prophylactic in
oral hygiene aimed at eliminating pathogenic bacteria.
Direct applications might include mouthwash and toothpaste;
- As a topical
biodegradable polymer matrix to assist in wound healing; and
- As a research agent
in clinical microbiology and epidemiology.
In the agricultural market, phages can be
sold for the following uses:
- To reduce and
potentially eradicate intestinal colonization with pathogenic
microorganisms, such as Salmonella in chickens and E. coli
in cattle. Direct application might include powders that can be
suspended in drinking water or mixed with food.
- To treat seeds and
plants against specific “problem” microorganisms;
- For environmental
clean-up of chicken houses and
poultry processing plants, which would substantially reduce
the risk that other flocks would be infected with the specific pathogen;
- To treat bacterial
infections, especially those caused by pathogenic
microorganisms against which there are no available or effective
antibiotics; and
- To monitor bacterial
contamination in the environment.
|
|
